Real-world clinical, endoscopic and radiographic efficacy of vedolizumab for the treatment of inflammatory bowel disease.
Paulo Gustavo KotzeChristopher MaAbdulelah AlmutairdiAhmed Al-DarmakiShane M DevlinGilaad G KaplanCynthia H-T SeowKerri L NovakCathy LuJose G P FerrazMichael J StewartMichelle BuresiHumberto JijonMeena MathivananJoan HeatheringtonMarie-Louise MartinRemo PanaccionePublished in: Alimentary pharmacology & therapeutics (2018)
Vedolizumab was effective for induction and maintenance of clinical and objective remission, both in Crohn's disease and ulcerative colitis.